Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This is a study to look at the effectiveness, tolerability, and safety of one dose of
rasagiline in advanced Parkinson's disease (PD) patients who have been treated with
Levodopa/Carbidopa therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries